NCT00002096View on ClinicalTrials.gov

A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

Not specified

Conditions

Cytomegalovirus InfectionsHIV Infections

Interventions

DRUG

Zidovudine

DRUG

Didanosine

DRUG

Ganciclovir

Trial Locations (3)

20007

Georgetown Univ Med Ctr, Washington D.C.

77550

Univ TX Galveston Med Branch, Galveston

92718

Ctr for Special Immunology, Irvine

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY